Shares of Sysmex Corporation ADR (OTCMKTS:SSMXY - Get Free Report) saw strong trading volume on Thursday . 346,829 shares were traded during trading, an increase of 321% from the previous session's volume of 82,297 shares.The stock last traded at $16.79 and had previously closed at $16.68.
Sysmex Price Performance
The firm has a market cap of $10.62 billion, a P/E ratio of 30.14 and a beta of 1.14. The company has a fifty day moving average price of $16.92 and a two-hundred day moving average price of $17.98. The company has a current ratio of 2.97, a quick ratio of 2.30 and a debt-to-equity ratio of 0.12.
Sysmex (OTCMKTS:SSMXY - Get Free Report) last posted its quarterly earnings results on Wednesday, May 14th. The company reported $0.12 earnings per share for the quarter, missing the consensus estimate of $0.16 by ($0.04). The company had revenue of $958.89 million for the quarter, compared to analyst estimates of $991.22 million. Sysmex had a return on equity of 11.81% and a net margin of 10.56%. Equities analysts anticipate that Sysmex Corporation ADR will post 0.57 earnings per share for the current year.
About Sysmex
(
Get Free Report)
Sysmex Corporation engages in the development, manufacture, and sale of diagnostic instruments, reagents, and related software in Japan. It offers three-part and five-part white blood cell differentiation instruments for use in hematology; and transport systems for high-volume testing in labs. The company also provides automated urine particle analyzers; automated blood coagulation analyzers; automated immunochemistry systems, which perform assays on minute sample quantities, as well as reagents to test for infectious disease and tumor markers; and flow cytometers to perform analysis in diagnosing leukemia, malignant lymphoma, and HIV/AIDS.
Featured Articles
Before you consider Sysmex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Sysmex wasn't on the list.
While Sysmex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access